-
Friday, 04/28/2023
The viral load of COVID-19 at admission to the ICU determines the prognosis of patients
Madrid, April 26, 2023. New research reveals the importance of 'viral storm' in critical patients with COVID-19. The work is published in the journal The Lancet Microbe and has been carried out by several groups in the area of Respiratory Diseases (CIBERES) and the area of Infectious Diseases (CIBERINFEC) of the Biomedical Research Center in Network (CIBER)consortium attached to the Carlos III Health Institute (ISCIII). The results show that viral load in blood at admission to the ICU is a determining factor in the prognosis of critical patients with COVID-19.
-
Thursday, 04/20/2023
33rd European Congress of Clinical Microbiology and Infectious Diseases
33rd European Congress of Clinical Microbiology and Infectious Diseases in Copenhagen, Denmark April 15-18, 2023
Our researchers have participated in the Congress with oral sessions, presentations and many posters you can see following:
-
Wednesday, 04/05/2023
Specific clinical guidelines published for severe community-acquired pneumonia
Researchers from the Hospital Clínic-IDIBAPS have co-led a document on the management of severe community-acquired pneumonia, published simultaneously in the European Respiratory Journal and Intensive Care Medicine.
These are clinical guidelines that provide recommendations to standardize the treatment and management of the most critical patients.
-
Monday, 03/27/2023
Inhaled amikacin for pneumonia treatment and dissemination prevention: an experimental model of severe monolateral Pseudomonas aeruginosa pneumonia
On February 14th, 2023, an article was published in the journal Critical Care titled "Inhaled amikacin for pneumonia treatment and dissemination prevention: an experimental model of severe monolateral Pseudomonas aeruginosa pneumonia". This study, conducted by an international team of researchers led by Dr. Antoni Torres, focuses on the treatment of pneumonia caused by Pseudmonas aeruginosa.
-
Friday, 01/20/2023
Researchers from IAMR group publish in Nature Biotechnology a ‘Living medicine’ created to tackle drug-resistant lung infections.
This excellent result comes from a collaborative consortium in which our IDIBAPS-Ciberes group added an important translational value on this new promising technology developed by CRG, also with the collaboration of Institute of Agrobiotechnology (IdAB), a joint research institute of Spain’s CSIC and the government of Navarre. https://www.nature.com/articles/s41587-022-01584-9#citeas.
Researchers have designed the first ‘living medicine’ to treat lung infections. The treatment targets Pseudomonas aeruginosa, a type of bacteria which is naturally resistant to many types of antibiotics and is a common source of infections in hospitals.
The treatment involves using a modified version of the bacterium Mycoplasma pneumoniae, removing its ability to cause disease and repurposing it to attack P. aeruginosa instead. The modified bacterium is used in combination with low doses of antibiotics that would otherwise not work on their own.
Researchers tested the efficacy of the treatment in mice, finding that it significantly reduced lung infections. The ‘living medicine’ doubled mouse survival rate compared to not using any treatment. Administering a single, high dose of the treatment showed no signs of toxicity in the lungs. Once the treatment had finished its course, the innate immune system cleared the modified bacteria in a period of four days.
-
Wednesday, 01/18/2023
Anna Motos Galera read her doctoral thesis
Anna Motos Galera read her doctoral thesis
Anna Motos read her doctoral thesis on December 21st 2022 at the Faculty of Medicine of the University of Barcelona. Her thesis entitled: Novel antimicrobial agents and therapeutic approaches for nosocomial pneumonia caused by Pseudomonas aeruginosa has obtained the Cum Laude qualification.
Congratulations Anna!
-
Thursday, 11/17/2022
New doctoral thesis read!
Congratulations Rubén López
New doctoral thesis read!
Rubén López Aladid read his doctoral thesis on October 20th at the Faculty of Biology of the University of Barcelona. His thesis entitled: The role of the microbiota in patients with bronchiectasis not associated with cystic fibrosis has obtained the Cum Laude qualification.
Congratulations Rubén!
-
Thursday, 10/20/2022
Welcome to new fellow researchers!
New stays in the Research Group
Mariana Bichuette Cartuliares
Respiratory physiotherapist, MSc. in health science, and Ph.D. student in emergency medicine.
From Denmark, staying here from the 1st to the 21st of October 2022.
During her study stay, she is learning about diagnostics methods including animal research and FilmArray. In addition, She is learning and assisting in the microbiological culture of lower respiratory specimens and biopsies.
-
Thursday, 10/20/2022
Welcome to new fellow researchers!
Francisco José Molina Saladriga
PhD student, MSc. Specialist in critical care medicine.
From Medellin, Colombia. Staying from October 11 to November 24, 2022
He is learning from molecular biology techniques: FilmArray and microbiome in pneumonia.
-
Wednesday, 09/28/2022
The big participation of our researchers in the European Respiratory Congress, Barcelona 2022
The big participation of our researchers in the European Respiratory Congress, Barcelona 2022
Here is the list of Abstracts presented by our researchers in the European Respiratory Congress held in Barcelona 2022:
Relationship between the microbiome and the GOLD Stage during exacerbations. Laia Fernandez Barat (Barcelona, Spain), Ruben Lopez-Aladid, Leticia Bueno-Freire, Adrian Ceccato, Arturo Huerta, Nestor Soler, Antoni Torres
Association of sleep quality-quantity with sedentary time and physical activity in bronchiectasis Victoria Alcaraz Serrano (Barcelona, Spain), Beatriz Herrero-Cortina, Ane Arbillaga-Etxarri, Rodrigo Torres-Castro, Joan Daniel Martí-Romeu, Laia Fernández-Barat, Antoni Torres-Martí, Elena Gimeno-Santos
Risk factors for mortality in COPD patients with COVID-19 admitted to Intensive Care Unit. Laia Fernandez Barat (Barcelona, Spain), Sergio Alvarez-Napagao, Marta Barroso, Ana Motos, Albert Gabarrús, Adrian Ceccato, Raquel Pérez, Dario García, Denise Battaglini, Andrea Palomeque, Jesús Bermejo, Ferran Barbé, Antoni Torres
One year overview of follow-up in a post-covid consultation of critical patients with covid-19. Jessica Gonzalez Gutierrez (Lleida, Spain), Maria Zuil, Iván D. Benítez, Maria Aguilà, Sally Santisteve, Fatty Seck, Anna Moncusí-Moix, Clara Gort-Paniello, Antoni Torres, Ferran Barbé
Prognostic implications of comorbidity patterns in critically ill COVID-19 patients. Jordi De Batlle Garcia (Lleida, Spain), Iván D Benítez, Gerard Torres, Jessica González, David De Gonzalo-Calvo, Adriano D S Targa, Antoni Torres, Ferran Barbé
COVID-19 in Ventilated Elderly Patients: Data from 52 Intensive Care Units in Spain. Catia Cilloniz Campos (Barcelona, Spain), Anna Motos, Albert Gabarrus, Juan Manuel Pericas, Laia Fernandez, Tatiana Guadalupe Castañeda, Andrea Palomeque, Adrian Cecato, Antoni Torres
Identification of highly immunogenic epitopes in the SARS-CoV-2 Spike protein to produce monoclonal antibodies. Laia Fernandez Barat (Barcelona, Spain), Rubén López-Aladid, Leticia Bueno, Roc Farriol, Eduard Porta, Àlex López-Gavin, Ana Motos, Ruth Aguilar, Marta Vidal, Alfons Jiménez, Roberto Cabrera, Nil Vázquez, Enric Barbeta, Miquel Ferrer, Andrea Catalina Palomeque, Gemma Moncunill, Miquel Lozano, Alberto Garcia-Basteiro, Carlota Dobaño, Antoni Torres
Proteomic determinants of disease, mortality and sequelae in COVID-19 patients requiring invasive mechanicalventilation. Marta Molinero García (Lleida, Spain), Silvia Gómez, Ivan D Benítez, Jj Vengoechea, Jessica González, Clara Gort-Paniello, Anna Moncusí-Moix, María C García-Hidalgo, Manel Pérez-Pons, Gerard Torres, Jesús Caballero, Carme Barberà, Adrián Ceccato, Laia Fernández-Barat, Ricard Ferrer, Dario García-Gasulla, Rosario Menéndez, Ana Motos, Óscar Peñuelas, Jordi Riera, Jesús F Bermejo-Martín, Antoni Torres, Ferran Barbé, David De Gonzalo-Calvo, D. Chalmers
Association between the viscoelastic characteristics and sputum colour in patients with bronchiectasis. Leticia Bueno Freire (Barcelona, Spain), Leticia Bueno-Freire , Nona Rovira, Victoria Alcaraz-Serrano, Héctor Sanz-Fraile, Nil Vàzquez-Burgos, Rosanel Amaro-Rodríguez, Patricia Oscanoa, Ruben López-Aladid, Andrea Palomeque, Ramon Farré, Jorge Otero, Laia Fernández-Barat *, Antoni Torres*
PSP kinetics in the prediction of VAP diagnosis. Adrian Ceccato (Ituzaingo (Prov. De Buenos Aires), Argentina), Marta Camprubi, Lieuwe Bos, Pedro Povoa, Ignacio Martin-Loeches, Aina Areny, Elena Campaña, Luis Morales, Paula Ramirez, Mariano Esperatti, Antoni Torres, Antonio Artigas
Towards a better diagnostic and treatment of ventilator-associated respiratory infections. Andrea Palomeque Flores (BARCELONA, Spain), Rubén López, Alba Soler, Leticia Bueno, Nona Rovira, Enric Barbeta, Ana Motos, Miriam Villanueva, Nil Vázques, Roberto Cabrera, Antonio Torres*, Laia Fernández-Barat*
Major candidate variables to guide personalized treatment with corticosteroids in critically ill patients with COVID-19: CIBERESUCICOVID study. Ana Motos Galera (Barcelona, Spain), Catia Cillóniz, Adrian Ceccato, Laia Fernández-Barat, Antoni Torres
Exacerbation risk factors in bronchiectasis colonized by Pseudomonas aeruginosa. Leticia Bueno Freire (Barcelona, Spain), Victoria Alcaraz Serrano, Nil Vázquez Burgos, Andrea Palomeque Flores, Patricia Oscanoa Huamán, Roberto Cabrera Ortega, Rubén López Aladid, Rosanel Amaro, Adrián Ceccato, Laia Fernández Barat*, Antoni Torres*
Validation of IDSA/ATS guidelines for ICU admission in very elderly patients with community-acquired pneumonia. Miquel Ferrer Monreal (Barcelona, Spain), Catia Cilloniz Campos, Juan Manuel Pericas, Leyre Serrano, Raul Mendez,Rosario Menendez, Luis Alberto Ruiz, Antoni Torres
ESTIMATING THE RISK OF BACTEREMIA IN HOSPITALIZED PATIENTS WITH PNEUMOCOCCAL PNEUMONIA. Leyre Serrano Fernandez (Bilbao (Bizkaia), Spain), Luis Alberto Ruiz Iturriaga, Silvia Perez Fernandez, Pedro Pablo España Yandiola, Catia Cilloniz, Beatriz Gonzalez Quero, Alejandro Rezola Carasusan, Ane Uranga , Antoni Torres Martí, Rafael Zalacain Jorge
Proteomic profiling of severe lung diffusion impairment in the recovery stage of COVID-19-induced ARDS. María C García-Hidalgo (Lleida, Spain), Jessica González, Iván D Benítez, Sally Santisteve, Fátima Rodríguez-Jara, Marta Molinero, Manel Pérez-Pons, Gerard Torres, Anna Moncusí-Moix, Clara Gort-Paniello, Paola Carmona, Jesús Caballero, Carme Barberà, Ana P. Tedim, Raquel Almansa, Adrián Ceccato, Laia Fernández-Barat, Ricard Ferrer, Dario García-Casulla, Rosario Menéndez, Anna Motos, Óscar Peñuelas, Jordi Riera, Jesús F Bermejo-Martín, Antoni Torres, Ferrán Barbé, David De Gonzalo-Calvo
The efficacy of telavancin in comparison to linezolid on endotracheal tube biofilm in pigs with MRSA pneumonia. KASRA KIAROSTAMI (Barcelona, Spain), Denise Battaglini, Anna Motos, Leticia Bueno Freire, Alba Soler Comas, Hua Yang, Minlan Yang, Francesco Pagliara, Eli Aguilera Xiol, Andrea Meli, Joaquim Bobi, Tarek Senussi Testa, FrancescoI done , Montserrat Rigol, Gianluigi Li Bassi, Laia Fernández-Barat, Antoni Torres
